NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-111531

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied(1) bacterial infections (Finibax indicatitons), (2) meningitis
Date of first enrollment
Target sample size
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : S-4661 INN of the intervention : doripenem monohydrate Dosage And administration of the intervention : Intravenous infusion Control intervention name : null

Outcome(s)

Primary OutcomeEfficacy
Secondary OutcomeSafety, pharmacokinetics

Key inclusion & exclusion criteria

Age minimum
Age maximum
GenderBOTH
Include criteriaHospitalized pediatrics from 28 days to less than 16 years with meningitis and other bacterial infections requiring intravenous antibiotic (carbapenem) therapy, etc.
Exclude criteriaPatients with a previous history of anaphylactic reactions or serious hypersensitivity to doripenem Patients with serious hepatic impairment or patients with serious renal impairment And et al.

Related Information

Contact

public contact
Name Shionogi & Co., Ltd. Corporate Communications Department
Address http://www.shionogi.co.jp/information/inquiry_entrance.html
Telephone
E-mail
Affiliation
scientific contact
Name
Address
Telephone
E-mail
Affiliation